Cargando…

A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages

BACKGROUND: Rosacea, a chronic inflammatory skin disorder etiologically associated with immune cells and the antibacterial peptide cathelicidin LL-37, can be effectively treated by oral carvedilol administration. OBJECTIVE: To investigate the molecular mechanisms underlying carvedilol efficacy in ro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jiawen, Jiang, Peiyu, Sheng, Lei, Liu, Yunyi, Liu, Yixuan, Li, Min, Tao, Meng, Hu, Liang, Wang, Xiaoyan, Yang, Yanjing, Xu, Yang, Liu, Wentao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311793/ https://www.ncbi.nlm.nih.gov/pubmed/34322115 http://dx.doi.org/10.3389/fimmu.2021.609615

Ejemplares similares

Corrigendum: A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages
por: Zhang, Jiawen, et al.
Publicado: (2022)

Paeoniflorin inhibits the macrophage-related rosacea-like inflammatory reaction through the suppressor of cytokine signaling 3-apoptosis signal-regulating kinase 1-p38 pathway
por: Liu, Zijing, et al.
Publicado: (2021)

Objectively quantifying facial erythema in rosacea aided by the ImageJ analysis of VISIA red images
por: Tao, Meng, et al.
Publicado: (2022)

Evaluation of skin barrier function based on skin dermoscopic features in patients with rosacea
por: Liu, Yixuan, et al.
Publicado: (2023)

The role of macrophages in rosacea: implications for targeted therapies
por: Liu, Yi, et al.
Publicado: (2023)

Role of Toll-Like Receptors in Neuroimmune Diseases: Therapeutic Targets and Problems
por: Li, Haixia, et al.
Publicado: (2021)

Escherichia coli adhesion portion FimH polarizes M2 macrophages to M1 macrophages in tumor microenvironment via toll-like receptor 4
por: Zhang, Wei, et al.
Publicado: (2023)

Toll-Like Receptors Drive Specific Patterns of Tolerance and Training on Restimulation of Macrophages
por: Butcher, Suzanne K., et al.
Publicado: (2018)

Caveolin-1 regulates OMV-induced macrophage pro-inflammatory activation and multiple Toll-like receptors
por: Sivanantham, Ayyanar, et al.
Publicado: (2023)

Toll-Like Receptors Gene Polymorphisms in Autoimmune Disease
por: Zhang, Yingchi, et al.
Publicado: (2021)

Toll-like Receptors and Inflammatory Bowel Disease
por: Lu, Yue, et al.
Publicado: (2018)

Effect of carvedilol on cardiomyocyte apoptosis in a rat model of myocardial infarction: A role for toll-like receptor 4
por: Liu, Qingwei, et al.
Publicado: (2013)

Repositioning of the β-Blocker Carvedilol as a Novel Autophagy Inducer That Inhibits the NLRP3 Inflammasome
por: Wong, Wei-Ting, et al.
Publicado: (2018)

The Toll for Trafficking: Toll-Like Receptor 7 Delivery to the Endosome
por: Petes, Carlene, et al.
Publicado: (2017)

Toll-Like Receptor Ligands and Interferon-γ Synergize for Induction of Antitumor M1 Macrophages
por: Müller, Elisabeth, et al.
Publicado: (2017)

Toll-Like Receptor 2 Release by Macrophages: An Anti-inflammatory Program Induced by Glucocorticoids and Lipopolysaccharide
por: Hoppstädter, Jessica, et al.
Publicado: (2019)

Immunohistochemical Analysis of Differences of Toll-Like Receptor 2, Mast Cells, and Neurofilaments between Granulomatous Rosacea and Non-Granulomatous Rosacea
por: Jang, Ye Ji, et al.
Publicado: (2021)

Roles of Toll-Like Receptor 3 in Human Tumors
por: Zheng, Xin, et al.
Publicado: (2021)

MyD88-dependent signaling drives toll-like receptor-induced trained immunity in macrophages
por: Owen, Allison M., et al.
Publicado: (2022)

Toll-Like Receptors Recognize Intestinal Microbes in Liver Cirrhosis
por: Fan, Yujing, et al.
Publicado: (2021)

Toll-like receptor-mediated innate immunity orchestrates adaptive immune responses in HBV infection
por: Du, Yanqin, et al.
Publicado: (2022)

Toll-Like Receptors of Deuterostome Invertebrates
por: Satake, Honoo, et al.
Publicado: (2012)

Toll-Like Receptors and Skin Cancer
por: Burns, Erin M., et al.
Publicado: (2014)

Toll-Like Receptors and Prostate Cancer
por: Zhao, Shu, et al.
Publicado: (2014)

Toll-Like Receptor Signaling Pathways
por: Kawasaki, Takumi, et al.
Publicado: (2014)

Toll-Like Receptors in Esophageal Cancer
por: Kauppila, Joonas H., et al.
Publicado: (2014)

Ulvan Activates Chicken Heterophils and Monocytes Through Toll-Like Receptor 2 and Toll-Like Receptor 4
por: Guriec, Nathalie, et al.
Publicado: (2018)

Amplified Host Defense by Toll-Like Receptor-Mediated Downregulation of the Glucocorticoid-Induced Leucine Zipper (GILZ) in Macrophages
por: Hoppstädter, Jessica, et al.
Publicado: (2019)

Toll-like receptor-targeted anti-tumor therapies: Advances and challenges
por: Yang, Yang, et al.
Publicado: (2022)

Toll-like receptor 4 confers inflammatory response to Suilysin
por: Bi, Lili, et al.
Publicado: (2015)

Toll-Like Receptor- and Protein Kinase R-Induced Type I Interferon Sustains Infection of Leishmania donovani in Macrophages
por: Dias, Bruna T., et al.
Publicado: (2022)

Inhibition of human macrophage activation via pregnane neurosteroid interactions with toll-like receptors: Sex differences and structural requirements
por: Balan, Irina, et al.
Publicado: (2022)

Toll-Like Receptor 9 in Breast Cancer
por: Sandholm, Jouko, et al.
Publicado: (2014)

The Role of Toll-Like Receptors in Hematopoietic Malignancies
por: Monlish, Darlene A., et al.
Publicado: (2016)

Identifying the neural basis for rosacea using positron emission tomography‐computed tomography cerebral functional imaging analysis: A cross‐sectional study
por: Liu, Yunyi, et al.
Publicado: (2022)

Finding a Toll on the Route: The Fate of Osteoclast Progenitors After Toll-Like Receptor Activation
por: Souza, Pedro P. C., et al.
Publicado: (2019)

Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity
por: Duan, Tianhao, et al.
Publicado: (2022)

Toll-like Interleukin 1 Receptor Regulator Is an Important Modulator of Inflammation Responsive Genes
por: Kashem, Mohammad Abul, et al.
Publicado: (2019)

How Toll-like receptors influence Parkinson’s disease in the microbiome–gut–brain axis
por: Zhang, Ziyi, et al.
Publicado: (2023)

The Novel Toll-Like Receptor 2 Agonist SUP3 Enhances Antigen Presentation and T Cell Activation by Dendritic Cells
por: Guo, Xueheng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bjmin5093ro1tge572d282c32k